Avatar for Vium

Creating Digital Biomarkers To Transform Translational Research

Creating Digital Biomarkers To Transform Translational Research

Vium empowers biomedical investigators with technology that accelerates the preclinical drug discovery and development pipeline. Researchers can design, run, and analyze experiments that rapidly surface insights and high volumes of quality data. The Vium platform improves the speed and reproducibility of preclinical research so that it is more predictive of how drugs perform in humans. The result is that better therapies get moved more quickly to patients who need them.
Founded OQO, sold IP to Google. Biophysics work at Caltech and Harvard. Not-for-profit: Health Extension Foundation. Intense focus in Biopharma: Vium.com
CEO and co-founder of Vium. 20 years start-up experience. VP Proteus. Many US patents and scholarly publications. Princeton AB and Berkeley PhD in Physics.